The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Companion Animal Therapeutics-Global Market Insights and Sales Trends 2024
Synopsis
The global Companion Animal Therapeutics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Companion Animal Therapeutics in various end use industries. The expanding demands from the Dogs, Cats, Horses and Other, are propelling Companion Animal Therapeutics market. Infectious Diseases, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dermatological Diseases segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 22%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Companion Animal Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Companion Animal Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Companion Animal Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Companion Animal Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Companion Animal Therapeutics covered in this report include Aratana Therapeutics, Elanco, Boehringer Ingelheim GmbH, Ceva Sante Animale, Dechra Pharmaceuticals, Eli Lilly and Company, Merck, Vetoquinol and Zoetis, etc.
The global Companion Animal Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Aratana Therapeutics
Elanco
Boehringer Ingelheim GmbH
Ceva Sante Animale
Dechra Pharmaceuticals
Eli Lilly and Company
Merck
Vetoquinol
Zoetis
Global Companion Animal Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Companion Animal Therapeutics market, Segment by Type:
Infectious Diseases
Dermatological Diseases
Orthopedic Diseases
Behavioral Disorders
Others
Global Companion Animal Therapeutics market, by Application
Dogs
Cats
Horses
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Companion Animal Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Companion Animal Therapeutics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Companion Animal Therapeutics in various end use industries. The expanding demands from the Dogs, Cats, Horses and Other, are propelling Companion Animal Therapeutics market. Infectious Diseases, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dermatological Diseases segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 22%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Companion Animal Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Companion Animal Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Companion Animal Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Companion Animal Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Companion Animal Therapeutics covered in this report include Aratana Therapeutics, Elanco, Boehringer Ingelheim GmbH, Ceva Sante Animale, Dechra Pharmaceuticals, Eli Lilly and Company, Merck, Vetoquinol and Zoetis, etc.
The global Companion Animal Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Aratana Therapeutics
Elanco
Boehringer Ingelheim GmbH
Ceva Sante Animale
Dechra Pharmaceuticals
Eli Lilly and Company
Merck
Vetoquinol
Zoetis
Global Companion Animal Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Companion Animal Therapeutics market, Segment by Type:
Infectious Diseases
Dermatological Diseases
Orthopedic Diseases
Behavioral Disorders
Others
Global Companion Animal Therapeutics market, by Application
Dogs
Cats
Horses
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Companion Animal Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Companion Animal Therapeutics
1.1 Companion Animal Therapeutics Market Overview
1.1.1 Companion Animal Therapeutics Product Scope
1.1.2 Companion Animal Therapeutics Market Status and Outlook
1.2 Global Companion Animal Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Companion Animal Therapeutics Market Size by Region (2018-2029)
1.4 Global Companion Animal Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Companion Animal Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Companion Animal Therapeutics Market Size (2018-2029)
1.6.1 North America Companion Animal Therapeutics Market Size (2018-2029)
1.6.2 Europe Companion Animal Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Companion Animal Therapeutics Market Size (2018-2029)
1.6.4 Latin America Companion Animal Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Companion Animal Therapeutics Market Size (2018-2029)
2 Companion Animal Therapeutics Market by Type
2.1 Introduction
2.1.1 Infectious Diseases
2.1.2 Dermatological Diseases
2.1.3 Orthopedic Diseases
2.1.4 Behavioral Disorders
2.1.5 Others
2.2 Global Companion Animal Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Companion Animal Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Companion Animal Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Companion Animal Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Companion Animal Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Companion Animal Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Companion Animal Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Companion Animal Therapeutics Revenue Breakdown by Type (2018-2029)
3 Companion Animal Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Dogs
3.1.2 Cats
3.1.3 Horses
3.1.4 Other
3.2 Global Companion Animal Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Companion Animal Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Companion Animal Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Companion Animal Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Companion Animal Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Companion Animal Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Companion Animal Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Companion Animal Therapeutics Revenue Breakdown by Application (2018-2029)
4 Companion Animal Therapeutics Competition Analysis by Players
4.1 Global Companion Animal Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Companion Animal Therapeutics as of 2022)
4.3 Date of Key Players Enter into Companion Animal Therapeutics Market
4.4 Global Top Players Companion Animal Therapeutics Headquarters and Area Served
4.5 Key Players Companion Animal Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Companion Animal Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Aratana Therapeutics
5.1.1 Aratana Therapeutics Profile
5.1.2 Aratana Therapeutics Main Business
5.1.3 Aratana Therapeutics Companion Animal Therapeutics Products, Services and Solutions
5.1.4 Aratana Therapeutics Companion Animal Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Aratana Therapeutics Recent Developments
5.2 Elanco
5.2.1 Elanco Profile
5.2.2 Elanco Main Business
5.2.3 Elanco Companion Animal Therapeutics Products, Services and Solutions
5.2.4 Elanco Companion Animal Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Elanco Recent Developments
5.3 Boehringer Ingelheim GmbH
5.3.1 Boehringer Ingelheim GmbH Profile
5.3.2 Boehringer Ingelheim GmbH Main Business
5.3.3 Boehringer Ingelheim GmbH Companion Animal Therapeutics Products, Services and Solutions
5.3.4 Boehringer Ingelheim GmbH Companion Animal Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Ceva Sante Animale Recent Developments
5.4 Ceva Sante Animale
5.4.1 Ceva Sante Animale Profile
5.4.2 Ceva Sante Animale Main Business
5.4.3 Ceva Sante Animale Companion Animal Therapeutics Products, Services and Solutions
5.4.4 Ceva Sante Animale Companion Animal Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Ceva Sante Animale Recent Developments
5.5 Dechra Pharmaceuticals
5.5.1 Dechra Pharmaceuticals Profile
5.5.2 Dechra Pharmaceuticals Main Business
5.5.3 Dechra Pharmaceuticals Companion Animal Therapeutics Products, Services and Solutions
5.5.4 Dechra Pharmaceuticals Companion Animal Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Dechra Pharmaceuticals Recent Developments
5.6 Eli Lilly and Company
5.6.1 Eli Lilly and Company Profile
5.6.2 Eli Lilly and Company Main Business
5.6.3 Eli Lilly and Company Companion Animal Therapeutics Products, Services and Solutions
5.6.4 Eli Lilly and Company Companion Animal Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Eli Lilly and Company Recent Developments
5.7 Merck
5.7.1 Merck Profile
5.7.2 Merck Main Business
5.7.3 Merck Companion Animal Therapeutics Products, Services and Solutions
5.7.4 Merck Companion Animal Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Merck Recent Developments
5.8 Vetoquinol
5.8.1 Vetoquinol Profile
5.8.2 Vetoquinol Main Business
5.8.3 Vetoquinol Companion Animal Therapeutics Products, Services and Solutions
5.8.4 Vetoquinol Companion Animal Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Vetoquinol Recent Developments
5.9 Zoetis
5.9.1 Zoetis Profile
5.9.2 Zoetis Main Business
5.9.3 Zoetis Companion Animal Therapeutics Products, Services and Solutions
5.9.4 Zoetis Companion Animal Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 Zoetis Recent Developments
6 North America
6.1 North America Companion Animal Therapeutics Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Companion Animal Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Companion Animal Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Companion Animal Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Companion Animal Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Companion Animal Therapeutics Market Dynamics
11.1 Companion Animal Therapeutics Industry Trends
11.2 Companion Animal Therapeutics Market Drivers
11.3 Companion Animal Therapeutics Market Challenges
11.4 Companion Animal Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
